Patent · US Active

Injection solution of an LHRH antagonist

US7790686B2 · kind B2 · utility

0Cited by
2References
7Claims
0Family size

Inventors

Key dates

Filing dateFeb 27, 2007
Grant dateSep 7, 2010
Priority date
Expiry dateMar 3, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/26
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An aqueous injectable solution of an LHRH antagonist, such as Cetrorelix, in an organic, pharmaceutically acceptable acid, such as gluconic acid.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.